Quantitative Approaches to Drug Discovery and
Precision Medicine: A Joint QBI-PRiME Symposium

Co-organized by Drs. Nevan Krogan, Brian Shoichet and Molly Shoichet, the Quantitative Biosciences Institute (QBI) at the University of California, San Francisco and PRiME Next-Generation Precision Medicine at the University of Toronto present a joint symposium on "Quantitative Approaches to Drug Discovery and Precision Medicine" in San Francisco on November 8, 2024.

QBI seeks transformative results in biomedicine by supporting fundamental quantitative research in the biological sciences through significant collaborative efforts. PRiME is an institutional strategic initiative at the University of Toronto, dedicated to addressing unmet needs and challenges in drug discovery, diagnostics, and disease biology. PRiME brings together a powerful continuum of world-class basic and clinical scientists, biomedical engineers, innovators, and entrepreneurs, fostering seamless collaborations with Toronto’s precision medicine ecosystem and global partners.

The symposium aims to build collaborative relationships between scientists from both institutions. The intersection of drug discovery and personalized medicine with quantitative biology, machine learning and artificial intelligence opens new opportunities for discovery and training, ultimately leading to translation and new therapeutics for improved human health.

The event will highlight cutting edge research with a view towards a partnership between QBI and PRiME.